Clinical Trial Update: Trimetazidine as an Adjunct to Enhance Clopidogrel Response. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating trimetazidine as an adjunct to improve clopidogrel response in patients with platelet dysfunction due to drugs; trial complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Platelet Dysfunction
• Platelet Dysfunction Due to Drugs

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Trimetazidine (trimetazidine)

Snippet

Sponsor: The University of The West Indies | Conditions: Platelet Dysfunction Due to Drugs | Phase 2 | Status: COMPLETED